CD8+ T Cells Are Required for Glatiramer Acetate Therapy in Autoimmune Demyelinating Disease

PLoS ONE - United States
doi 10.1371/journal.pone.0066772
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Public Library of Science (PLoS)

Related search

Th17 Cells in Autoimmune Demyelinating Disease

Seminars in Immunopathology
AllergyImmunology
2010English

CD8+ Regulatory T Cells Are Critical in Prevention of Autoimmune-Mediated Diabetes

Nature Communications
AstronomyGeneticsMolecular BiologyBiochemistryChemistryPhysics
2020English

018 Langerhans Cells Suppress CD8 T Cells in Situ During Acute Graft-Versus-Host Disease-Like Autoimmune Mucocutaneous Disease

Journal of Investigative Dermatology
BiochemistryDermatologyCell BiologyMolecular Biology
2019English

CD8+ T Cells and Endogenous IL-10 Are Required for Resolution of Chemotherapy-Induced Neuropathic Pain

Journal of Neuroscience
Neuroscience
2016English

Both Perforin and Fas Ligand Are Required for the Regulation of Alloreactive CD8+ T Cells During Acute Graft-Versus-Host Disease

Blood
BiochemistryImmunologyCell BiologyHematology
2005English

Regulatory T Cells Subdue an Autoimmune Disease

Nature
Multidisciplinary
2019English

Demyelination Arrest and Remyelination Induced by Glatiramer Acetate Treatment of Experimental Autoimmune Encephalomyelitis

Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
2008English

Β2-Glycoprotein I-Reactive T Cells in Autoimmune Disease

Frontiers in Immunology
AllergyImmunology
2018English

In Vitro Evidence That Cytokine Receptor Signals Are Required for Differentiation of Double Positive Thymocytes Into Functionally Mature CD8+T Cells

Journal of Experimental Medicine
MedicineAllergyImmunology
2003English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy